Beyond GI effects, patients should watch for: Headaches , particularly during the first two weeks and after dose escalations Insomnia or sleep disruption, which affects some patients more than others Muscle pain and body aches , often reported in the first week of a new dose Anxiety , which some patients experience as appetite suppression creates unfamiliar hunger signals Joint pain , reported less frequently but worth monitoring Injection site reactions , including redness, itching, and localized swelling Menstrual changes , as rapid weight loss and hormonal shifts can affect cycle regularity Fatigue , especially during the caloric restriction phase Hair loss , a known but usually temporary effect of significant weight loss If side effects become unmanageable at any dose, the microdose tirzepatide schedule offers an alternative approach
How does retatrutide work in the body
Avoid smoking: Smoking weakens the protective lining of the stomach, making it more vulnerable to acid and inflammation
Patients should report severe abdominal pain, thyroid symptoms, or persistent nausea promptly, and continue routine breast cancer surveillance as recommended
Can be incorporated alongside other research peptides and compound stacks as part of broader protocols
